[English] 日本語
Yorodumi
- PDB-1ben: INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1ben
TitleINSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE
Components(HUMAN INSULINInsulin (medication)) x 2
KeywordsHORMONE / INSULIN / GLUCOSE METABOLISM
Function / homology
Function and homology information


negative regulation of NAD(P)H oxidase activity / negative regulation of glycogen catabolic process / regulation of cellular amino acid metabolic process / Signaling by Insulin receptor / IRS activation / negative regulation of fatty acid metabolic process / nitric oxide-cGMP-mediated signaling / Insulin processing / negative regulation of feeding behavior / regulation of protein secretion ...negative regulation of NAD(P)H oxidase activity / negative regulation of glycogen catabolic process / regulation of cellular amino acid metabolic process / Signaling by Insulin receptor / IRS activation / negative regulation of fatty acid metabolic process / nitric oxide-cGMP-mediated signaling / Insulin processing / negative regulation of feeding behavior / regulation of protein secretion / positive regulation of peptide hormone secretion / Regulation of gene expression in beta cells / positive regulation of respiratory burst / positive regulation of dendritic spine maintenance / alpha-beta T cell activation / negative regulation of acute inflammatory response / negative regulation of respiratory burst involved in inflammatory response / negative regulation of protein secretion / fatty acid homeostasis / Synthesis, secretion, and deacylation of Ghrelin / positive regulation of glycogen biosynthetic process / positive regulation of lipid biosynthetic process / Signal attenuation / FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes / negative regulation of gluconeogenesis / positive regulation of nitric oxide mediated signal transduction / regulation of protein localization to plasma membrane / COPI-mediated anterograde transport / negative regulation of lipid catabolic process / negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway / negative regulation of reactive oxygen species biosynthetic process / positive regulation of insulin receptor signaling pathway / transport vesicle / positive regulation of protein autophosphorylation / insulin-like growth factor receptor binding / Insulin receptor recycling / NPAS4 regulates expression of target genes / positive regulation of protein metabolic process / endoplasmic reticulum-Golgi intermediate compartment membrane / neuron projection maintenance / positive regulation of brown fat cell differentiation / activation of protein kinase B activity / positive regulation of glycolytic process / Insulin receptor signalling cascade / positive regulation of mitotic nuclear division / Regulation of insulin secretion / positive regulation of nitric-oxide synthase activity / positive regulation of long-term synaptic potentiation / endosome lumen / positive regulation of cytokine production / acute-phase response / positive regulation of protein secretion / regulation of transmembrane transporter activity / positive regulation of cell differentiation / positive regulation of glucose import / negative regulation of proteolysis / regulation of synaptic plasticity / wound healing / insulin receptor binding / negative regulation of protein catabolic process / positive regulation of neuron projection development / hormone activity / cognition / vasodilation / Golgi lumen / positive regulation of protein localization to nucleus / glucose metabolic process / regulation of protein localization / glucose homeostasis / cell-cell signaling / insulin receptor signaling pathway / positive regulation of NF-kappaB transcription factor activity / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / positive regulation of cell growth / secretory granule lumen / protease binding / positive regulation of MAPK cascade / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / positive regulation of cell migration / G protein-coupled receptor signaling pathway / Amyloid fiber formation / endoplasmic reticulum lumen / Golgi membrane / negative regulation of gene expression / positive regulation of cell population proliferation / positive regulation of gene expression / regulation of DNA-templated transcription / extracellular space / extracellular region / identical protein binding
Similarity search - Function
Insulin / Insulin family / Insulin/IGF/Relaxin family / Insulin, conserved site / Insulin family signature. / Insulin-like / Insulin / insulin-like growth factor / relaxin family. / Insulin-like superfamily
Similarity search - Domain/homology
4-HYDROXYBENZAMIDE / Insulin
Similarity search - Component
MethodX-RAY DIFFRACTION / Resolution: 1.4 Å
AuthorsSmith, G.D. / Ciszak, E. / Pangborn, W.
Citation
Journal: Protein Sci. / Year: 1996
Title: A novel complex of a phenolic derivative with insulin: structural features related to the T-->R transition.
Authors: Smith, G.D. / Ciszak, E. / Pangborn, W.
#1: Journal: Structure / Year: 1995
Title: Role of C-Terminal B-Chain Residues in Insulin Assembly: The Structure of Hexameric Lysb28Prob29-Human Insulin
Authors: Ciszak, E. / Beals, J.M. / Frank, B.H. / Baker, J.C. / Carter, N.D. / Smith, G.D.
#2: Journal: Biochemistry / Year: 1994
Title: Crystallographic Evidence for Dual Coordination Around Zinc in the T3R3 Human Insulin Hexamer
Authors: Ciszak, E. / Smith, G.D.
#3: Journal: Proc.Natl.Acad.Sci.USA / Year: 1994
Title: The Structure of a Complex of Hexameric Insulin and 4'-Hydroxyacetanilide
Authors: Smith, G.D. / Ciszak, E.
#4: Journal: Proteins / Year: 1992
Title: The Structure of a Rhombohedral R6 Insulin/Phenol Complex
Authors: Smith, G.D. / Dodson, G.G.
#6: Journal: Proc.Natl.Acad.Sci.USA / Year: 1984
Title: Structural Stability in the 4-Zinc Human Insulin Hexamer
Authors: Smith, G.D. / Swenson, D.C. / Dodson, E.J. / Dodson, G.G. / Reynolds, C.D.
History
DepositionFeb 15, 1996-
Revision 1.0Jul 11, 1996Provider: repository / Type: Initial release
Revision 1.1Mar 3, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)12,0769
Polymers11,6354
Non-polymers4415
Water3,027168
1
A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)5,8833
Polymers5,8182
Non-polymers651
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area1670 Å2
ΔGint-14 kcal/mol
Surface area3680 Å2
MethodPISA
2
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)6,1936
Polymers5,8182
Non-polymers3754
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area1340 Å2
ΔGint-10 kcal/mol
Surface area3930 Å2
MethodPISA
3
A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)36,22827
Polymers34,90612
Non-polymers1,32215
Water21612
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area20450 Å2
ΔGint-264 kcal/mol
Surface area11720 Å2
MethodPISA
4
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)36,22827
Polymers34,90612
Non-polymers1,32215
Water21612
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
crystal symmetry operation1_556x,y,z+11
crystal symmetry operation2_556-y,x-y,z+11
crystal symmetry operation3_556-x+y,-x,z+11
Buried area13770 Å2
ΔGint-245 kcal/mol
Surface area18410 Å2
MethodPISA
5
D: HUMAN INSULIN
hetero molecules

D: HUMAN INSULIN
hetero molecules

D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)36,22827
Polymers34,90612
Non-polymers1,32215
Water21612
TypeNameSymmetry operationNumber
crystal symmetry operation1_554x,y,z-11
crystal symmetry operation2_554-y,x-y,z-11
crystal symmetry operation3_554-x+y,-x,z-11
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area10050 Å2
ΔGint-214 kcal/mol
Surface area22120 Å2
MethodPISA
6
A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
C: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)25,21215
Polymers24,6049
Non-polymers6086
Water1629
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area7890 Å2
ΔGint-91 kcal/mol
Surface area15130 Å2
MethodPISA
7
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)18,57818
Polymers17,4536
Non-polymers1,12512
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area6300 Å2
ΔGint-141 kcal/mol
Surface area9730 Å2
MethodPISA
8
A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)17,6499
Polymers17,4536
Non-polymers1963
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area6000 Å2
ΔGint-87 kcal/mol
Surface area10140 Å2
MethodPISA
9
B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

B: HUMAN INSULIN
C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)29,07624
Polymers27,7559
Non-polymers1,32215
Water1629
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area14940 Å2
ΔGint-220 kcal/mol
Surface area11430 Å2
MethodPISA
10
A: HUMAN INSULIN
B: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)28,66521
Polymers27,7559
Non-polymers91012
Water1629
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area13870 Å2
ΔGint-226 kcal/mol
Surface area11430 Å2
MethodPISA
11
D: HUMAN INSULIN
hetero molecules

D: HUMAN INSULIN
hetero molecules

D: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules

A: HUMAN INSULIN
B: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)28,66521
Polymers27,7559
Non-polymers91012
Water1629
TypeNameSymmetry operationNumber
crystal symmetry operation1_554x,y,z-11
crystal symmetry operation2_554-y,x-y,z-11
crystal symmetry operation3_554-x+y,-x,z-11
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area8160 Å2
ΔGint-209 kcal/mol
Surface area17140 Å2
MethodPISA
12
B: HUMAN INSULIN
hetero molecules

B: HUMAN INSULIN
hetero molecules

B: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

C: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)29,07624
Polymers27,7559
Non-polymers1,32215
Water1629
TypeNameSymmetry operationNumber
crystal symmetry operation1_556x,y,z+11
crystal symmetry operation2_556-y,x-y,z+11
crystal symmetry operation3_556-x+y,-x,z+11
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area8210 Å2
ΔGint-196 kcal/mol
Surface area18160 Å2
MethodPISA
13
B: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

B: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules

B: HUMAN INSULIN
D: HUMAN INSULIN
hetero molecules


Theoretical massNumber of molelcules
Total (without water)21,51418
Polymers20,6046
Non-polymers91012
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555-y,x-y,z1
crystal symmetry operation3_555-x+y,-x,z1
Buried area8630 Å2
ΔGint-184 kcal/mol
Surface area10850 Å2
MethodPISA
Unit cell
Length a, b, c (Å)80.720, 80.720, 37.630
Angle α, β, γ (deg.)90.00, 90.00, 120.00
Int Tables number146
Space group name H-MH3
Components on special symmetry positions
IDModelComponents
11B-31-

ZN

21D-31-

ZN

31D-32-

CL

41B-48-

HOH

51D-107-

HOH

61D-116-

HOH

DetailsTHE CRYSTALLOGRAPHIC ASYMMETRIC UNIT OF INSULIN CONSISTS OF TWO INSULIN MONOMERS EACH CONSISTING OF TWO HETEROCHAINS. THE ENTRY PRESENTS COORDINATES FOR MONOMER I (CHAIN IDENTIFIERS A AND B) AND II (CHAIN IDENTIFIERS C AND D). APPLYING THE THREE-FOLD CRYSTALLOGRAPHIC SYMMETRY AXIS YIELDS A HEXAMER AROUND THE AXIS. THERE ARE TWO ZINC IONS AND ONE CHLORIDE ION PER INSULIN HEXAMER LOCATED ON THE THREE-FOLD AXIS AND HAVE OCCUPANCIES OF 0.33. WATERS HOH 18, HOH 54, AND HOH 59 ARE LOCATED ON THE THREE-FOLD AXIS.

-
Components

-
Protein/peptide , 2 types, 4 molecules ACBD

#1: Protein/peptide HUMAN INSULIN / Insulin (medication) / INSULIN


Mass: 2383.698 Da / Num. of mol.: 2 / Source method: obtained synthetically / Details: GIFT OF LILLY RESEARCH LABORATORIES / References: UniProt: P01308
#2: Protein/peptide HUMAN INSULIN / Insulin (medication) / INSULIN


Mass: 3433.953 Da / Num. of mol.: 2 / Source method: obtained synthetically / Details: GIFT OF LILLY RESEARCH LABORATORIES / References: UniProt: P01308

-
Non-polymers , 4 types, 173 molecules

#3: Chemical ChemComp-ZN / ZINC ION


Mass: 65.409 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: Zn
#4: Chemical ChemComp-HBD / 4-HYDROXYBENZAMIDE


Mass: 137.136 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C7H7NO2
#5: Chemical ChemComp-CL / CHLORIDE ION / Chloride


Mass: 35.453 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Cl
#6: Water ChemComp-HOH / water / Water


Mass: 18.015 Da / Num. of mol.: 168 / Source method: isolated from a natural source / Formula: H2O

-
Details

Compound detailsTHE CONFORMATIONS OF THE TWO MONOMERS ARE DIFFERENT AS THE RESULT OF A DIFFERENCE IN CONFORMATION ...THE CONFORMATIONS OF THE TWO MONOMERS ARE DIFFERENT AS THE RESULT OF A DIFFERENCE IN CONFORMATION AT THE N-TERMINI OF THE B AND D CHAINS. IN MONOMER I, B 1 - B 8 ADOPT AN EXTENDED CONFORMATION (T STATE) WHILE IN MONOMER II RESIDUES D 4 THROUGH D 8 ARE ALPHA-HELICAL (RF STATE).
Nonpolymer detailsTHE MODEL ALSO CONTAINS TWO ZINC IONS. THE FIRST ZINC ION (ZN B 31) IS COORDINATED BY THREE ...THE MODEL ALSO CONTAINS TWO ZINC IONS. THE FIRST ZINC ION (ZN B 31) IS COORDINATED BY THREE SYMMETRY RELATED HIS B 10 SIDE CHAINS AND THE SECOND (ZN D 31) BY THREE SYMMETRY RELATED HIS D 10 SIDE CHAINS. THE COORDINATION SPHERE OF ZN B 31 IS OCTAHEDRAL WITH THE REMAINING THREE SITES FILLED BY WATER, HOH 1. THE COORDINATION OF ZN D 31 IS TETRAHEDRAL TO CL D 32.

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 6

-
Sample preparation

CrystalDensity Matthews: 2.03 Å3/Da / Density % sol: 33 %
Description: DATA WERE MEASURED FROM SIX CRYSTALS, GROWN IN MICROGRAVITY ON SHUTTLE FLIGHT, STS-60. THE R-AXIS-IIC SOFTWARE WAS USED TO INTEGRATE EACH IMAGE PLATE; SCALING AND MERGING WAS ...Description: DATA WERE MEASURED FROM SIX CRYSTALS, GROWN IN MICROGRAVITY ON SHUTTLE FLIGHT, STS-60. THE R-AXIS-IIC SOFTWARE WAS USED TO INTEGRATE EACH IMAGE PLATE; SCALING AND MERGING WAS ACCOMPLISHED WITH THE DREAM PROGRAM PACKAGE (R.H. BLESSING, CRYSTALLOGR. REV. 1, 3-58 (1987).
Crystal growMethod: slow cooling / pH: 5.7
Details: 0.05M SODIUM CITRATE, 0.007M ZINC ACETATE, 0.06M 4-HYDROXYBENZAMIDE, 1.0M SODIUM CHLORIDE, PH=5.7. CRYSTALS GROWN BY SLOW COOLING., slow cooling
Crystal
*PLUS
Crystal grow
*PLUS
Method: unknown
Components of the solutions
*PLUS
IDConc.Common nameCrystal-IDSol-IDChemical formula
10.9 mMinsulin11
20.05 Msodium citrate11
30.007 Mzinc acetate11
40.06 M4-hydroxybenzamide11
51.0 M11NaCl

-
Data collection

Diffraction sourceWavelength: 1.5418
DetectorType: RIGAKU RAXIS IIC / Detector: IMAGE PLATE / Date: Feb 14, 1994
RadiationMonochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.5418 Å / Relative weight: 1
ReflectionResolution: 1.4→80 Å / Num. obs: 18002 / % possible obs: 76.6 % / Observed criterion σ(I): 2 / Redundancy: 8.6 % / Rmerge(I) obs: 0.066
Reflection
*PLUS
Num. measured all: 159339

-
Processing

SoftwareName: PROFFT / Classification: refinement
RefinementResolution: 1.4→8 Å / σ(F): 2 /
Num. reflection% reflection
obs13694 76.5 %
Displacement parametersBiso mean: 27.4 Å2
Refinement stepCycle: LAST / Resolution: 1.4→8 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms807 0 23 227 1057
Refine LS restraints
Refine-IDTypeDev idealDev ideal target
X-RAY DIFFRACTIONp_bond_d0.0140.02
X-RAY DIFFRACTIONp_angle_d0.0340.04
X-RAY DIFFRACTIONp_angle_deg
X-RAY DIFFRACTIONp_planar_d0.0140.04
X-RAY DIFFRACTIONp_hb_or_metal_coord
X-RAY DIFFRACTIONp_mcbond_it1.942
X-RAY DIFFRACTIONp_mcangle_it3.143
X-RAY DIFFRACTIONp_scbond_it2.022
X-RAY DIFFRACTIONp_scangle_it3.373
X-RAY DIFFRACTIONp_plane_restr0.0150.025
X-RAY DIFFRACTIONp_chiral_restr0.1260.15
X-RAY DIFFRACTIONp_singtor_nbd0.1830.5
X-RAY DIFFRACTIONp_multtor_nbd0.2250.5
X-RAY DIFFRACTIONp_xhyhbond_nbd
X-RAY DIFFRACTIONp_xyhbond_nbd0.2490.5
X-RAY DIFFRACTIONp_planar_tor3.33.5
X-RAY DIFFRACTIONp_staggered_tor14.720
X-RAY DIFFRACTIONp_orthonormal_tor
X-RAY DIFFRACTIONp_transverse_tor1525
X-RAY DIFFRACTIONp_special_tor
Refinement
*PLUS
σ(I): 17907 / Rfactor all: 0.176 / Rfactor obs: 0.154 / Rfactor Rwork: 0.183
Solvent computation
*PLUS
Displacement parameters
*PLUS

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more